ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 63 filers reported holding ENTRADA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $41,040 | +565.8% | 2,880 | +562.1% | 0.00% | – |
Q1 2024 | $6,164 | -92.9% | 435 | -92.5% | 0.00% | -100.0% |
Q4 2023 | $87,220 | +450.4% | 5,780 | +476.3% | 0.00% | – |
Q3 2023 | $15,847 | +76.2% | 1,003 | +68.9% | 0.00% | – |
Q2 2023 | $8,993 | +47231.6% | 594 | -54.0% | 0.00% | -100.0% |
Q1 2023 | $19 | +216.7% | 1,292 | +189.0% | 0.00% | – |
Q4 2022 | $6 | -100.0% | 447 | -82.2% | 0.00% | -100.0% |
Q3 2022 | $40,000 | +73.9% | 2,508 | +0.9% | 0.00% | – |
Q1 2022 | $23,000 | -45.2% | 2,485 | +0.3% | 0.00% | -100.0% |
Q4 2021 | $42,000 | – | 2,478 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 4,425,784 | $75,769,000 | 16.37% |
5AM Venture Management, LLC | 4,408,379 | $75,471,000 | 14.16% |
72 Investment Holdings, LLC | 509,024 | $8,714,000 | 7.73% |
TCG Crossover Management, LLC | 663,694 | $11,362,000 | 5.32% |
Redmile Group, LLC | 1,954,420 | $33,460,000 | 0.76% |
StepStone Group LP | 761,277 | $13,033,000 | 0.74% |
Baker Brothers Advisors | 4,704,419 | $80,540,000 | 0.39% |
Avidity Partners Management LP | 255,000 | $4,366,000 | 0.09% |
MOORE CAPITAL MANAGEMENT, LP | 105,000 | $1,798,000 | 0.04% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 106,000 | $1,815,000 | 0.04% |